文献速递糖尿病肥胖与代谢综合征

脐血代谢标志物是母亲肥胖影响糖耐量谱系妊娠胎儿生长的强中介因素:PANDORA研究

Cord blood metabolic markers are strong mediators of the effect of maternal adiposity on fetal growth in pregnancies across the glucose tolerance spectrum: the PANDORA study.
PubMed 文献 · Diabetologia · 2020-01-08

基于PANDORA观察性队列1135对母婴中645例单胎脐血样本,覆盖正常糖耐量、妊娠期糖尿病和孕前2型糖尿病。脐血C肽升高与出生体重z评分、皮褶厚度总和、体脂百分比及大于胎龄儿风险显著相关,并中介母亲BMI与大于胎龄儿关联的18%及与新生儿体脂百分比关联的11%。

要点

  • 脐血C肽升高与出生体重z评分、皮褶厚度总和、体脂百分比及大于胎龄儿风险显著正相关。
  • 脐血C肽中介母亲BMI与大于胎龄儿关联的18%(95%CI 13,36)。
  • 脐血C肽中介母亲BMI与新生儿体脂百分比关联的11%(95%CI 8,17)。

核心结论

  • 脐血C肽是母亲与婴儿肥胖关联的重要中介因素,且这一中介作用跨越母亲糖耐量谱系。

研究设计与样本

  • PANDORA研究为观察性队列,纳入1135对母婴,其中645例单胎婴儿有脐静脉血可用(49%为澳大利亚原住民)。
  • 母亲糖耐量分组:正常糖耐量129例、妊娠期糖尿病419例、2型糖尿病97例。
  • 检测脐血葡萄糖、三酰甘油、HDL胆固醇、C反应蛋白和C肽,采用多变量logistic和线性回归及通路分析。

主要发现

  • 调整年龄、种族和糖尿病类型后,脐血C肽升高与出生体重z评分升高相关(β 0.57 [95% CI 0.42, 0.71])。
  • 脐血C肽升高与皮褶厚度总和升高相关(β 0.83 [95% CI 0.41, 1.25])。
  • 脐血C肽升高与体脂百分比升高相关(β 1.20 [95% CI 0.69, 1.71])。
  • 脐血C肽升高与大于胎龄儿风险相关(OR 3.14 [95% CI 2.11, 4.68])。
  • 仅在澳大利亚原住民女性中,脐血三酰甘油与出生体重z评分呈负相关;脐血葡萄糖、HDL胆固醇和CRP >0.3 mg/l(2.9 nmol/l)与新生儿结局无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We aimed to assess associations between cord blood metabolic markers and fetal overgrowth, and whether cord markers mediated the impact of maternal adiposity on neonatal anthropometric outcomes among children born to Indigenous and Non-Indigenous Australian women with normal glucose tolerance (NGT), gestational diabetes mellitus (GDM) and pregestational type 2 diabetes mellitus. METHODS: From the Pregnancy and Neonatal Outcomes in Remote Australia (PANDORA) study, an observational cohort of 1135 mother-baby pairs, venous cord blood was available for 645 singleton babies (49% Indigenous Australian) of women with NGT (n = 129), GDM (n = 419) and type 2 diabetes (n = 97). Cord glucose, triacylglycerol, HDL-cholesterol, C-reactive protein (CRP) and C-peptide were measured. Multivariable logistic and linear regression were used to assess the associations between cord blood metabolic markers and the outcomes of birthweight z score, sum of skinfold thickness (SSF), being large for gestational age (LGA) and percentage of body fat. Pathway analysis assessed whether cord markers mediated the associations between maternal and neonatal adiposity. RESULTS: Elevated cord C-peptide was significantly associated with increasing birthweight z score (β 0.57 [95% CI 0.42, 0.71]), SSF (β 0.83 [95% CI 0.41, 1.25]), percentage of body fat (β 1.20 [95% CI 0.69, 1.71]) and risk for LGA [OR 3.14 [95% CI 2.11, 4.68]), after adjusting for age, ethnicity and diabetes type. Cord triacylglycerol was negatively associated with birthweight z score for Indigenous Australian women only. No associations between cord glucose, HDL-cholesterol and CRP >0.3 mg/l (2.9 nmol/l) with neonatal outcomes were observed. C-peptide mediated 18% (95% CI 13, 36) of the association of maternal BMI with LGA and 11% (95% CI 8, 17) of the association with per cent neonatal fat. CONCLUSIONS/INTERPRETATION: Cord blood C-peptide is an important mediator of the association between maternal and infant adiposity, across the spectrum of maternal glucose tolerance.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Lee IL, Barr ELM, Longmore D, et al. Cord blood metabolic markers are strong mediators of the effect of maternal adiposity on fetal growth in pregnancies across the glucose tolerance spectrum: the PANDORA study. Diabetologia. 2020. PMID: 31915893. doi:10.1007/s00125-019-05079-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。